Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
Kimihiko Kaneko(Fukushima Medical University), Masashi Aoki(Tohoku University), Dagoberto Callegaro(Universidade de São Paulo), Shuhei Nishiyama(Fukushima Medical University), Patrick Waters(University of Oxford), María Sepúlveda(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Sasitorn Siritho(Siriraj Hospital), Naraporn Prayoonwiwat(Mahidol University), Satoru Tanaka(Saitama Medical University), Thomas Berger(Medical University of Vienna), Markus Reindl(Innsbruck Medical University), Ichiro Nakashima(Tohoku University), Kazuo Fujihara(Tohoku University), Jae‐Won Hyun(Seoul National University Hospital), Hiroshi Kuroda(Fukushima Medical University), Albert Saiz(Hospital Clínic de Barcelona), Douglas Kazutoshi Sato(Fukushima Medical University), Romain Marignier(Inserm), Ho Jin Kim(National Cancer Center), Thomas Seifert‐Held(Medical University of Graz), Luana Michelli de Oliveira(Universidade de São Paulo), Kyoichi Nomura(Saitama Medical University), Tetsuya Akaishi(Tohoku University Hospital), Kazuhiro Kurosawa(Tohoku University), Tatsuro Misu(Fukushima Medical University)
Cited by 108
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Toll-like Receptor 4 Polymorphisms and Atherogenesis
|New England Journal of Medicine|2002|1k